N-((R)-Carbamoylphenylmethyl)-N-((R)-1-phenylethyl)benzamide

ID: ALA4786793

PubChem CID: 118246720

Max Phase: Preclinical

Molecular Formula: C23H22N2O2

Molecular Weight: 358.44

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H](c1ccccc1)N(C(=O)c1ccccc1)[C@@H](C(N)=O)c1ccccc1

Standard InChI:  InChI=1S/C23H22N2O2/c1-17(18-11-5-2-6-12-18)25(23(27)20-15-9-4-10-16-20)21(22(24)26)19-13-7-3-8-14-19/h2-17,21H,1H3,(H2,24,26)/t17-,21-/m1/s1

Standard InChI Key:  YFQRFEAYDFPJMW-DYESRHJHSA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   43.0745   -1.3454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.0733   -2.1691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.7855   -2.5822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.4993   -2.1686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.4965   -1.3418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.7837   -0.9366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.7853   -3.4035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.0734   -3.8119    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   44.4970   -3.8123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.2090   -3.4039    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   44.4968   -4.6336    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   42.3616   -3.4032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6497   -3.8116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.9412   -3.3994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.2339   -3.8071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.2332   -4.6293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.9458   -5.0421    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6543   -4.6279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.3618   -2.5818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.0732   -4.6333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.3612   -5.0458    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   43.6537   -5.2127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.4407   -6.0040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.0164   -6.5790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.8079   -6.3677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.0165   -5.5719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.4393   -5.0003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  3  1  6
  7  8  1  0
  7  9  1  0
  9 10  1  0
  9 11  2  0
  8 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 12 19  1  1
  8 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
M  END

Associated Targets(Human)

TRPM8 Tclin Transient receptor potential cation channel subfamily M member 8 (1168 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR1I2 Tchem Pregnane X receptor (6667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 358.44Molecular Weight (Monoisotopic): 358.1681AlogP: 4.12#Rotatable Bonds: 6
Polar Surface Area: 63.40Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.02CX LogD: 4.02
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.72Np Likeness Score: -0.81

References

1. Kobayashi JI,Hirasawa H,Fujimori Y,Nakanishi O,Kamada N,Ikeda T,Yamamoto A,Kanbe H.  (2021)  Identification of N-acyl-N-indanyl-α-phenylglycinamides as selective TRPM8 antagonists designed to mitigate the risk of adverse effects.,  30  [PMID:33333445] [10.1016/j.bmc.2020.115903]

Source